The diagnosis of von Willebrand disease: A guideline from the UK Haemophilia Centre Doctors' Organization

被引：114

作者：

Laffan, M

Brown, SA

Collins, PW

Cumming, AM

Hill, FGH

Keeling, D

Peake, IR

Pasi, KJ

机构：

[1] Barts & London, Queen Marys Sch Med & Dent, Dept Haematol, UKHCDO von Willebrands Dis Working Party, London E1 2AD, England

[2] Hammersmith Hosp, Imperial Coll, Dept Haematol, London, England

[3] Royal Free Hosp, Dept Haematol, London NW3 2QG, England

[4] Univ Wales Hosp, Dept Haematol, Cardiff CF4 4XN, S Glam, Wales

[5] Manchester Royal Infirm, Dept Haematol, Manchester M13 9WL, Lancs, England

[6] Birmingham Childrens Hosp, Dept Haematol, Birmingham, W Midlands, England

[7] Churchill Hosp, Dept Haematol, Oxford OX3 7LJ, England

[8] Royal Hallamshire Hosp, Div Genom Med, Sheffield S10 2JF, S Yorkshire, England

来源：

HAEMOPHILIA | 2004年 / 10卷 / 03期

关键词：

bleeding; diagnosis; guidelines; haemostasis; UKHCDO; von Willebrand;

D O I：

10.1111/j.1365-2516.2004.00894.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

von Willebrand disease (VWD) is the commonest inherited bleeding disorder. However, despite an increasing understanding of the pathophysiology of VWD, the diagnosis of VWD is frequently difficult because of uncertainty regarding the relationship between laboratory assays and function in vivo. The objective of this guideline is to provide contemporary advice on a rational approach to the diagnosis of VWD. This is the second edition of this UK Haemophilia Centre Doctors' Organisation (UKHCDO) guideline and supersedes the previous edition which was published in 1997.

引用

页码：199 / 217

页数：19

共 90 条

[21] Favaloro EJ, 2000, THROMB HAEMOSTASIS, V84, P541
[22] Federici AB, 2000, THROMB HAEMOSTASIS, V84, P1127
[23] Federici AB, 2000, THROMB HAEMOSTASIS, V84, P345
[24] Diagnosis of von Willebrand disease
Federici, AB
[J]. HAEMOPHILIA, 1998, 4 (04) : 654 - 660
[25] Screening for von Willebrand disease with a new analyzer using high shear stress: A study of 60 cases
Fressinaud, E
Veyradier, A
Truchaud, F
Martin, I
Boyer-Neumann, C
Trossaert, M
Meyer, D
[J]. BLOOD, 1998, 91 (04) : 1325 - 1331
[26] PRETREATMENT PLASMA-LEVELS OF FIBRINOPEPTIDE-A (FPA), D-DIMER (DD), AND VON-WILLEBRAND FACTOR (VWF) IN PATIENTS WITH OPERABLE CERVICAL-CANCER - INFLUENCE OF SURGICAL PATHOLOGICAL STAGE, TUMOR SIZE, HISTOLOGIC TYPE, AND LYMPH-NODE STATUS
GADDUCCI, A
BAICCHI, U
MARRAI, R
FACCHINI, V
DELBRAVO, B
FOSELLA, PV
FIORETTI, P
[J]. GYNECOLOGIC ONCOLOGY, 1993, 49 (03) : 354 - 358
[27] GAUCHER C, 1994, BLOOD, V84, P1024
[28] GILL JC, 1987, BLOOD, V69, P1691
[29] MOLECULAR-BASIS OF HUMAN VONWILLEBRAND DISEASE - ANALYSIS OF PLATELET VONWILLEBRAND-FACTOR MESSENGER-RNA
GINSBURG, D
KONKLE, BA
GILL, JC
MONTGOMERY, RR
BOCKENSTEDT, PL
JOHNSON, TA
YANG, AY
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (10) : 3723 - 3727
[30] HEMORRHAGIC PROBLEMS IN OBSTETRICS AND GYNECOLOGY IN PATIENTS WITH CONGENITAL COAGULOPATHIES
GREER, IA
LOWE, GDO
WALKER, JJ
FORBES, CD
[J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1991, 98 (09): : 909 - 918

← 1 2 3 4 5 6 7 8 9 →